| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 146.400 | 220.420 | 229.834 | 255.904 | 209.827 | 245.111 | 281.013 | 259.572 | 249.744 | 250.511 |
| Venituri Totale - Ron | 138.108 | 222.749 | 229.575 | 265.793 | 210.130 | 249.482 | 290.840 | 250.499 | 252.373 | 258.303 |
| Cheltuieli Totale - Ron | 103.722 | 166.618 | 209.526 | 267.279 | 191.087 | 214.379 | 252.801 | 210.446 | 225.907 | 235.415 |
| Profit/Pierdere Brut - Ron | 34.386 | 56.131 | 20.049 | -1.486 | 19.043 | 35.103 | 38.039 | 40.053 | 26.466 | 22.888 |
| Profit/Pierdere Net - Ron | 29.932 | 48.699 | 11.744 | -4.334 | 16.860 | 32.811 | 35.713 | 38.017 | 24.215 | 21.796 |
| Salariati | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Verifica rapoartele financiare pentru firma - Noblesse Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 9.399 | 5.991 | 129.281 | 123.212 | 253.927 | 243.889 | 221.631 | 188.406 | 156.992 | 112.507 |
| Active Circulante | 97.392 | 123.510 | 139.018 | 161.750 | 104.844 | 120.515 | 119.022 | 151.658 | 190.253 | 247.935 |
| Stocuri | 44.754 | 40.405 | 40.288 | 34.742 | 35.892 | 46.460 | 58.715 | 54.120 | 51.192 | 103.755 |
| Creante | 51.731 | 61.201 | 95.827 | 109.197 | 25.701 | 16.970 | 8.522 | 6.512 | 10.746 | 9.755 |
| Casa si conturi | 907 | 21.904 | 2.903 | 17.811 | 43.251 | 57.085 | 51.785 | 91.026 | 128.315 | 134.425 |
| Capitaluri Proprii | 37.891 | 86.590 | 98.334 | 94.000 | 254.520 | 310.858 | 319.572 | 331.226 | 340.984 | 354.628 |
| Capital Social | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 | 57.280 |
| Datorii | 69.520 | 44.132 | 171.151 | 191.586 | 105.102 | 54.245 | 23.695 | 13.970 | 10.509 | 7.727 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "4646 - 4646" | |||||||||
| CAEN An Financiar |
4646
|
|||||||||
Comentarii - Noblesse Pharma Srl